Melitracen HCl ia potential dopamine D1/2 receptor antagonist used to treat depression. It is often co-administered with flupenthixol as a treatment for trigeminal neuralgia. It does not effect cardiovascular function. References: Thoma K, von Stein C. [The effect of changing the association properties of psychopharmaceuticals in colloidal solutions on their liberation. 4. The effect of chemical structure as well as environmental conditions on the elevation of critical micelle formation concentration and reduction of micelle weight with hydrotropic material]. Pharm Acta Helv. 1990;65(4):98-104. German. PubMed PMID: 2356194.

纯度：≥98%

CAS：10563-70-9